Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients.

Langman, L J; LeGatt, D F; Halloran, P F; Yatscoff, R W

Langman, L J; LeGatt, D F; Halloran, P F; Yatscoff, R W.

Affiliation

Langman LJ; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.

Transplantation ; 62(5): 666-72, 1996 Sep 15.

Article in En | MEDLINE | ID: mdl-8830834

Subject(s)

Enzyme Inhibitors/therapeutic use; Immunosuppressive Agents/therapeutic use; Kidney Transplantation/immunology; Mycophenolic Acid/therapeutic use; Azathioprine/therapeutic use; Drug Administration Schedule; Drug Monitoring/methods; Enzyme Inhibitors/pharmacokinetics; Enzyme Inhibitors/pharmacology; Humans; IMP Dehydrogenase/antagonists & inhibitors; IMP Dehydrogenase/blood; Immunosuppressive Agents/pharmacokinetics; Immunosuppressive Agents/pharmacology; Lymphocytes/drug effects; Lymphocytes/metabolism; Mycophenolic Acid/pharmacokinetics; Mycophenolic Acid/pharmacology; Purine Nucleotides/blood

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Kidney Transplantation / Enzyme Inhibitors / Immunosuppressive Agents / Mycophenolic Acid Type of study: Clinical_trials Limits: Humans Language: En Year: 1996 Type: Article

Search on Google

XML

PubMed Links